Study of efficacy and safety of VAY736 in patients with relapsing-remitting multiple sclerosis

Update Il y a 4 ans
Reference: EUCTR2013-002324-16

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To determine if a monoclonal antibody VAY736 can reduce disease activity in relapsing-remitting multiple sclerosis (RRMS) as compared to placebo.


Inclusion criteria

  • Relapsing-Remitting Multiple Sclerosis